Related Experiment Videos
Genomic imprinting--defusing the ovarian time bomb
Trends in Genetics : TIG
|April 1, 1994
Summary
Mammalian genomic imprinting protects females from ovarian trophoblast disease. This process prevents parthenogenetically activated oocytes from forming lethal cancers, increasing female fitness.
Area of Science:
- Genomics
- Developmental Biology
- Reproductive Health
Background:
- Genomic imprinting, the differential expression of alleles based on parental origin, is observed across various species.
- Mammalian genomic imprinting is particularly pronounced and complex compared to other phyla.
- The evolutionary drivers for such a dramatic phenomenon in mammals remain incompletely understood.
Purpose of the Study:
- To propose a novel hypothesis explaining the evolutionary advantage of genomic imprinting in female mammals.
- To investigate the potential role of imprinting in preventing ovarian trophoblast disease.
Main Methods:
- Theoretical modeling and evolutionary analysis were employed to explore the selective pressures favoring genomic imprinting.
- Literature review and comparative genomics were used to assess the prevalence and characteristics of imprinting across species.
Main Results:
- Mammalian imprinting may serve as a crucial mechanism to protect females from ovarian teratomas, which can arise from parthenogenetic oocytes.
- Without imprinting, these teratomas could potentially develop into malignant trophoblast, posing a lethal threat to females.
- An allele promoting imprinting would confer a significant survival advantage, leading to its rapid proliferation within the population.
Conclusions:
- Genomic imprinting in mammals is hypothesized to be a key adaptation for preventing lethal ovarian cancers in females.
- This imprinting mechanism safeguards female reproductive health by controlling trophoblast development originating from oocytes.
- The evolutionary persistence of imprinting is strongly linked to the suppression of a life-threatening condition specific to females.